Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

493 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
USP2a alters chemotherapeutic response by modulating redox.
Benassi B, Marani M, Loda M, Blandino G. Benassi B, et al. Among authors: loda m. Cell Death Dis. 2013 Sep 26;4(9):e812. doi: 10.1038/cddis.2013.289. Cell Death Dis. 2013. PMID: 24071644 Free PMC article.
MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer.
Benassi B, Flavin R, Marchionni L, Zanata S, Pan Y, Chowdhury D, Marani M, Strano S, Muti P, Blandino G, Loda M. Benassi B, et al. Among authors: loda m. Cancer Discov. 2012 Mar;2(3):236-47. doi: 10.1158/2159-8290.CD-11-0219. Epub 2012 Jan 5. Cancer Discov. 2012. PMID: 22585994 Free PMC article.
The isopeptidase USP2a protects human prostate cancer from apoptosis.
Priolo C, Tang D, Brahamandan M, Benassi B, Sicinska E, Ogino S, Farsetti A, Porrello A, Finn S, Zimmermann J, Febbo P, Loda M. Priolo C, et al. Among authors: loda m. Cancer Res. 2006 Sep 1;66(17):8625-32. doi: 10.1158/0008-5472.CAN-06-1374. Cancer Res. 2006. PMID: 16951176
PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis.
Linares JF, Zhang X, Martinez-Ordoñez A, Duran A, Kinoshita H, Kasashima H, Nakanishi N, Nakanishi Y, Carelli R, Cappelli L, Arias E, Yashiro M, Ohira M, Patel S, Inghirami G, Loda M, Cuervo AM, Diaz-Meco MT, Moscat J. Linares JF, et al. Among authors: loda m. Mol Cell. 2021 Nov 4;81(21):4509-4526.e10. doi: 10.1016/j.molcel.2021.08.039. Epub 2021 Sep 23. Mol Cell. 2021. PMID: 34560002 Free PMC article.
Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer.
Nanni S, Priolo C, Grasselli A, D'Eletto M, Merola R, Moretti F, Gallucci M, De Carli P, Sentinelli S, Cianciulli AM, Mottolese M, Carlini P, Arcelli D, Helmer-Citterich M, Gaetano C, Loda M, Pontecorvi A, Bacchetti S, Sacchi A, Farsetti A. Nanni S, et al. Among authors: loda m. Mol Cancer Res. 2006 Feb;4(2):79-92. doi: 10.1158/1541-7786.MCR-05-0098. Mol Cancer Res. 2006. PMID: 16513839
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.
Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M, Wu T, Regan MM, Meyer CA, Carroll JS, Manrai AK, Jänne OA, Balk SP, Mehra R, Han B, Chinnaiyan AM, Rubin MA, True L, Fiorentino M, Fiore C, Loda M, Kantoff PW, Liu XS, Brown M. Wang Q, et al. Among authors: loda m. Cell. 2009 Jul 23;138(2):245-56. doi: 10.1016/j.cell.2009.04.056. Cell. 2009. PMID: 19632176 Free PMC article.
MYC regulation of a "poor-prognosis" metastatic cancer cell state.
Wolfer A, Wittner BS, Irimia D, Flavin RJ, Lupien M, Gunawardane RN, Meyer CA, Lightcap ES, Tamayo P, Mesirov JP, Liu XS, Shioda T, Toner M, Loda M, Brown M, Brugge JS, Ramaswamy S. Wolfer A, et al. Among authors: loda m. Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3698-703. doi: 10.1073/pnas.0914203107. Epub 2010 Feb 4. Proc Natl Acad Sci U S A. 2010. PMID: 20133671 Free PMC article.
Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer.
Nanni S, Benvenuti V, Grasselli A, Priolo C, Aiello A, Mattiussi S, Colussi C, Lirangi V, Illi B, D'Eletto M, Cianciulli AM, Gallucci M, De Carli P, Sentinelli S, Mottolese M, Carlini P, Strigari L, Finn S, Mueller E, Arcangeli G, Gaetano C, Capogrossi MC, Donnorso RP, Bacchetti S, Sacchi A, Pontecorvi A, Loda M, Farsetti A. Nanni S, et al. Among authors: loda m. J Clin Invest. 2009 May;119(5):1093-108. doi: 10.1172/JCI35079. Epub 2009 Apr 13. J Clin Invest. 2009. PMID: 19363294 Free PMC article.
493 results